Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD
Randomized Double Blind Placebo-controlled Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD - The ABACOPD Study
Sponsor: CAPNETZ Stiftung
A PHASE4 clinical study on Chronic Obstructive Pulmonary Disease (COPD), this trial is completed. The trial is conducted by CAPNETZ Stiftung and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 5 earlier versions
-
Nov 2019 — Jul 2020 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Mar 2019 — Aug 2019 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CAPNETZ Stiftung
- Hannover Medical School
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aachen, Germany , Bad Arolsen, Germany , Ballenstedt, Germany , Berlin, Germany , Bochum, Germany , Bonn, Germany , Borstel, Germany , Dortmund, Germany , Dresden, Germany , Elgershausen, Germany and 16 more locations